ERBB2 and metastatic neoplasm: First, the substantial interpatient heterogeneity we observed in how well each metastatic tumor reflected its matched PT in phenotypic composition may be due in part to effects of treatment, which has been shown to affect clonal similarity of matched primary and metastatic sites (73) as well as similarity of hormone receptor and HER2 expression (14, 15).